Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to Record 8.0% Y-O-Y Growth Rate in 2022 | Evolving Opportunities with Amgen Inc. & Apollomics Inc.
/PRNewswire/ -- The epidermal growth factor receptor (EGFR) inhibitors market size is expected to grow by USD 6.75 billion from 2021 to 2026 at a CAGR of 8.6%...